Both in Biotechnology
Cel-Sci vs Aligos Therapeutics
Over the past year CVM returned −80.1% and ALGS returned −36.9%; their daily moves had a correlation of 0.06.
CVM −80.1% ALGS −36.9%Growth of $1, one year, split-adjusted
| Metric | CVM | ALGS |
|---|---|---|
| Price | $1.41 | $4.75 |
| Market cap | $24.8M | $29.7M |
| Today | +7.63% | +3.26% |
| 1 month | −41.7% | −12.0% |
| 6 months | −19.0% | −25.2% |
| Year to date | −73.2% | −49.0% |
| 1 year | −80.1% | −42.4% |
| Revenue growth (YoY) | — | +2778.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −5.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.9× |
| Net cash | $255.6K | $30.3M |
| Dividend yield | — | — |
| Volatility (60d) | 95.5% | 65.0% |
| Short % of float | 4.0% | 12.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).